{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:40:20Z","timestamp":1776440420414,"version":"3.51.2"},"reference-count":50,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007372","name":"Association Belge contre les Maladies Neuro-Musculaires","doi-asserted-by":"publisher","award":["aides \u00e0 la recherche 2016"],"award-info":[{"award-number":["aides \u00e0 la recherche 2016"]}],"id":[{"id":"10.13039\/100007372","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects. However, which of those mechanisms are cause and which effect, as well as their interrelations, remain partly obscured to this day. In this review the nature of the mitochondrial dysregulation in IBM muscle is explored and comparison is made with other muscle disorders. Mitochondrial alterations in IBM are evidenced by histological and serum biomarkers. Muscular mitochondrial dynamics is disturbed, with deregulated organelle fusion leading to subsequent morphological alterations and muscle displays abnormal mitophagy. The tissue increases mitochondrial content in an attempt to compensate dysfunction, yet mitochondrial DNA (mtDNA) alterations and mild mtDNA depletion are also present. Oxidative phosphorylation defects have repeatedly been shown, most notably a reduction in complex IV activities and levels of mitokines and regulatory RNAs are perturbed. Based on the cumulating evidence of mitochondrial abnormality as a disease contributor, it is therefore warranted to regard IBM as a mitochondrial disease, offering a feasible therapeutic target to be developed for this yet untreatable condition.<\/jats:p>","DOI":"10.3390\/biom9010015","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:22:31Z","timestamp":1547090551000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9403-4401","authenticated-orcid":false,"given":"Boel","family":"De Paepe","sequence":"first","affiliation":[{"name":"Neuromuscular Reference Centre, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1329197","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2012","journal-title":"Semin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/NEN.0b013e31826183c8","article-title":"Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis","volume":"71","author":"Askanas","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","article-title":"Inclusion body myositis: Laser microdissection reveals differential up-regulation of IFN-\u03b3 signaling cascade in attacked versus nonattacked myofibers","volume":"179","author":"Ivanidze","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1007\/s11926-013-0329-z","article-title":"Update on treatment of inclusion body myositis","volume":"15","author":"Breithaupt","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2019-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2012.05.003","article-title":"High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes","volume":"250","author":"James","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1212\/01.wnl.0000192127.63013.8d","article-title":"Mitochondrial abnormalities in inclusion-body myositis","volume":"66","author":"Oldfors","year":"2006","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","article-title":"Impaired autophagy in sporadic inclusion body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers","volume":"177","author":"Nogalska","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1042\/CS20160080","article-title":"Mitochondrial DNA disturbance and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis","volume":"130","author":"Garrabou","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1093\/nar\/gkw382","article-title":"Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis","volume":"44","author":"Rygiel","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1098-1004(1997)10:5<381::AID-HUMU8>3.0.CO;2-I","article-title":"Analysis of multiple mitochondrial DNA deletions in inclusion body myositis","volume":"10","author":"Moslemi","year":"1997","journal-title":"Hum. Mutat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0960-8966(18)30380-8","article-title":"Low mitochondrial DNA copy number suggests abnormal mitophagy in inclusion body myositis","volume":"28","author":"Brady","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Buzkova, J., Nikkanen, J., Ahola, S., Hakonen, A.H., Sevastianova, K., Hovinen, T., Yki-Jarvinen, H., Pietilainen, K.H., Lonnqvist, T., and Velagapudi, V. (2018). Metabolomes of mitochondrial diseases and inclusion body myositis patients: Treatment targets and biomarkers. EMBO Mol. Med., e9091.","DOI":"10.15252\/emmm.201809091"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tig.2004.07.003","article-title":"Two direct repeats cause most human mtDNA deletions","volume":"20","author":"Samuels","year":"2004","journal-title":"Trends Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.nmd.2014.12.010","article-title":"Mitochondrial pathology in inclusion body myositis","volume":"25","author":"Lindgren","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.410370107","article-title":"Ragged red fibers in normal aging and inflammatory myopathy","volume":"37","author":"Rifai","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0960-8966(02)00283-3","article-title":"A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome","volume":"13","author":"Nishigaki","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4236\/ojmip.2014.42002","article-title":"Mitochondrial dysregulation in skeletal muscle from patients diagnosed with Alzheimer\u2019s disease and sporadic inclusion body myositis","volume":"4","author":"Shabrokh","year":"2014","journal-title":"Open J. Mol. Integr. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0960-8966(02)00098-6","article-title":"Inclusion body myositis: Morphological clues to correct diagnosis","volume":"12","author":"Dahlbom","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e8024","DOI":"10.1038\/s41598-017-08603-9","article-title":"transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis","volume":"7","author":"Hamann","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.38292","article-title":"Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2014.05.047","article-title":"MicroRNA directly enhances mitochondrial translation during muscle differentiation","volume":"158","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1096\/fj.201600529R","article-title":"Impaired exercise tolerance, mitochondrial biogenesis, and uscle fiber maintenance in miR-133a-deficient mice","volume":"30","author":"Nie","year":"2016","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00294-017-0744-1","article-title":"How long noncoding RNAs enforce their will on mitochondrial activity: Regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer","volume":"64","author":"Lefever","year":"2018","journal-title":"Curr. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41556-018-0204-2","article-title":"Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria","volume":"20","author":"Wang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbadis.2014.09.005","article-title":"Sporadic inclsuion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy","volume":"1852","author":"Askanas","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/art.34508","article-title":"Mitochodnrial dysfunction increases inflammatory responsiveness to cytokines in normal human chondrocytes","volume":"64","author":"Blanco","year":"2012","journal-title":"Arthritis Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/nan.12149","article-title":"Mitochondrial and inflammatory changes in sporadic inclusion body myositis","volume":"41","author":"Rygiel","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"H2726","DOI":"10.1152\/ajpheart.00376.2007","article-title":"TNF-\u03b1-induced mitochondrial oxidative stress and cardiac dysfunction: Restoration by superoxide dismutase mimetic tempol","volume":"293","author":"Mariappan","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e13063","DOI":"10.14814\/phy2.13063","article-title":"Humanin skeletal muscle protein levels increase after resistance training in men with impaired glucose metabolism","volume":"4","author":"Gidlund","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: A diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1152\/ajpendo.00101.2017","article-title":"Fibroblast growth factor 21: A regulator of metabolic disease and health span","volume":"313","author":"Xie","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders","volume":"87","author":"Lehtonen","year":"2016","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.201607110","article-title":"Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis","volume":"216","author":"Chung","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kalko, S.G., Jou, C., Meznaric, M., Rogac, M., Jekovec-Vrhovsek, M., Sciacco, M., Moggio, M., Fagiolari, G., De Paepe, B., and De Meirleir, L. (2014). Transcriptomic profiling of thymidine kinase 2 deficient human skeletal muscle reveals activation of the p53 signaling pathway and identifies growth and differentiation 15 as a potential novel biomarker for mitochondrial myopathies. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-91"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jnc.13626","article-title":"Muscle biopsies from human muscle diseases with myopathic pathology reveal common alterations in mitochondrial function","volume":"138","author":"Sunitha","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","article-title":"Inflammatory myopathies with mitochondrial pathology and protein aggregates","volume":"278","author":"Temiz","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nmd.2018.01.004","article-title":"Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: Ultrastructural and immunohistochemical studies","volume":"28","author":"Matsubara","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00401-017-1731-9","article-title":"IFN-\u03b2-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis","volume":"134","author":"Meyer","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0022-510X(88)90211-0","article-title":"Perifascicular atrophic fibers in childhood dermatomyositis with particular reference to mitochondrial changes","volume":"88","author":"Woo","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"ref_42","first-page":"85","article-title":"Mitochondrial alterations in muscle biopsies of patients on statin therapy","volume":"36","author":"Gambelli","year":"2004","journal-title":"J. Submicrosc. Cytol. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2012.12.023","article-title":"Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy","volume":"325","author":"Stringer","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.88.16_supplement.P1.111","article-title":"RESILIENT: A randomized, double-blind, placebo-controlled study of bimagrumab in patients with sporadic inclusion body myositis","volume":"88","author":"Amato","year":"2017","journal-title":"Neurology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/CND.0b013e3181a23c86","article-title":"Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis","volume":"10","author":"Johnson","year":"2009","journal-title":"Clin. Neuromusc. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/JES.0b013e3182575599","article-title":"Exercise training-induced regulation of mitochondrial quality","volume":"40","author":"Yan","year":"2012","journal-title":"Exerc. Sport Sci. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19587","DOI":"10.1074\/jbc.M408862200","article-title":"Exercise stimulates PGC-1\u03b1 transcription in skeletal muscle through activation of the p38 MAPK pathway","volume":"280","author":"Akimoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1177\/0883073814538509","article-title":"Treatment of mitochondrial disorders: Antioxidants and beyond","volume":"29","author":"Enns","year":"2014","journal-title":"J. Child Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jocn.2014.05.051","article-title":"Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis","volume":"21","author":"Vetterke","year":"2014","journal-title":"J. Clin. Neurosci."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:24:00Z","timestamp":1760185440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["biom9010015"],"URL":"https:\/\/doi.org\/10.3390\/biom9010015","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]}}}